SURVYR

BCPC

Balchem Corporation
$170.62
−$6.38 (3.60%)Oct 26 close
MaterialsS&P 600 CompareTechnicals
1M3M6M1Y2Y
-7%0%+6%+13%+20%Oct 2025Oct 2026Apr 202652w high $183.9052w low $147.18
BCPCSPY
Wall St. Highest PT $242.00 (+41.8%) Wall St. Avg PT $209.25 (+22.6%)
$146$172$198$224$249POC $166Hi $242Avg $209
Underwater Drawdown %Max DD -14.7%Current -6.9%
0.0%-14.7%
Relative Strength vs SPY-1.8% vs SPYUnderperforming
+22%0%-22%
1W
+$0.20 (0.12%)
1M
+$2.73 (1.63%)
3M
+$5.83 (3.54%)
6M
−$4.50 (2.57%)
YTD
+$17.26 (11.25%)
1Y
+$14.90 (9.57%)

Chart

Loading live chart…

Ratings & dials

1m · 5m · 15m · 1h · 4h · 1D

Analyst & Morningstar ratings

Consensus · Targets · Morningstar
Wall Street analyst consensus
SellHoldStrong Buy
Buy
4 analysts · mean score 2.00
1 = Strong Buy · 5 = Sell
Wall Street consensus
Analyst price targets
Current price$170.62
Average target$209.25
+$38.63 (+22.6%) upsideaverage target vs current price
CurrentAverageMedian
Low$165.00
Median$209.25
High$242.00
12-month Wall Street target range
Recent analyst rating changes · 30
Reiterated
2026-08-03 · HC Wainwright & Co. reiterated Buy on BCPC
Reiterated
2026-05-04 · HC Wainwright & Co. reiterated Buy on BCPC
Reiterated
2026-02-24 · HC Wainwright & Co. reiterated Buy on BCPC
Initiated
2025-12-05 · Rothschild & Co started covering BCPC at Neutral
Reiterated
2025-10-22 · HC Wainwright & Co. reiterated Buy on BCPC
Reiterated
2025-08-04 · HC Wainwright & Co. reiterated Buy on BCPC
All analyst rating changes ›

Third-party ratings, not SURVYR.'s views.

Key stats & company

Market value$5.6B
P/E (last 12 months)34.7
P/E (next 12 months, estimated)28.1
52-week range$147.18 – $183.90
Revenue growth (latest quarter vs a year ago)+11.2%
Dividend yield0.56%
Analyst consensusBuy (4)
Average analyst price target$209.25 (+23%)

What they do

Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.

Basic Materials · Specialty Chemicals
Valuation and fundamentals

Valuation & fundamentals

Loading the valuation from SEC filings…

For information only · Important disclosures

Grades vs sector

Momentum
40th percentile in sector
C-
12-1 return: +8.2%
Percentile within its GICS sector across the S&P 1500.
Growth
60th percentile in sector
B-
Revenue growth (YoY): +11.2%
Percentile within its GICS sector across the S&P 1500.
Value
8th percentile in sector
F
Forward E/P: 3.7% · EBITDA/EV: 4.9%
Percentile within its GICS sector across the S&P 1500.
Profitability
70th percentile in sector
B
Profit margin: +15.1% · Return on equity: +12.8%
Percentile within its GICS sector across the S&P 1500.
Revisions
Not enough data yet
–
EPS estimate change, 30 days (current FY): –
30-day change in analysts' current-year EPS estimate; graded across covered stocks.

Systematic Models

Not held by any of our 7 live models right now.

Quality Growth
Outside this model's universe or screens
 Momentum Top 15
Outside this model's universe or screens
 Momentum Blend
Not in the current book
 New Highs Growth
Outside this model's universe or screens
 SURVYR. Barbell Momentum & T-Bill Shield
Outside this model's universe or screens
 SURVYR. Physical AI Grid & Power
Outside this model's universe or screens
 SURVYR. Long Book
Not in the current book

Earnings & events

BCPC earningsReported Oct 23, 2026▲ Above estimates
Results · Before the open
EPS actual$1.57
EPS estimate$1.54
Surprise+2.3%
RevenueNot in our data yet

Revenue for this quarter is not in our data yet. It arrives with the quarterly filing.

Next report · quarter Sep 2026
Fri Oct 23, 2026Before the open
EPS consensus$1.53 range $1.51–$1.56
Revenue consensus$289.2M 3 analysts
Last 4 quarters · EPS vs estimate
Oct 23, 2026$1.57est $1.54+2.3%Above estimates
Jul 31, 2026$1.49est $1.43+4.6%Above estimates
Apr 30, 2026$1.33est $1.330.0%In line with estimates
Feb 20, 2026$1.31est $1.29+1.9%Above estimates

In line = within 1% of the estimate.

Source: Yahoo Finance · report time: Nasdaq earnings calendar · refreshed 2026-10-23 13:56:58 ET
25-0225-0425-0725-1026-0226-0426-0726-100.001.57
EstimateActual (beat)Actual (miss)

Quarterly revenue

QuarterRevenueYoY
2026-03-31$270.7M+8.1%
2025-12-31$263.6M–
2025-09-30$267.6M–
2025-06-30$255.5M–
2025-03-31$250.5M–

Recent dividends

2025-12-23: $0.960 · 2024-12-26: $0.870 · 2023-12-26: $0.790 · 2022-12-23: $0.710 · 2021-12-27: $0.640 · 2020-12-24: $0.580 · 2019-12-27: $0.520 · 2018-12-24: $0.470

News & catalysts

More news
Balchem: 3 Key Takeaways for Long-Term Investors
Nasdaq · Oct 23
Balchem (BCPC) Q3 2026 Earnings Call Transcript
Nasdaq · Oct 23
Balchem Corp. Q3 Income Rises
Nasdaq · Oct 23
Balchem Corporation (BCPC) files 8-K: results
SEC 8-K · Oct 23
Rating changes
Reiterated
2026-08-03 · HC Wainwright & Co. reiterated Buy on BCPC
Reiterated
2026-05-04 · HC Wainwright & Co. reiterated Buy on BCPC
Reiterated
2026-02-24 · HC Wainwright & Co. reiterated Buy on BCPC
Initiated
2025-12-05 · Rothschild & Co started covering BCPC at Neutral
Reiterated
2025-10-22 · HC Wainwright & Co. reiterated Buy on BCPC
Reiterated
2025-08-04 · HC Wainwright & Co. reiterated Buy on BCPC

Third-party analyst actions, not SURVYR.'s views. All rating changes

Stats refreshed 2026-10-23 13:56:58 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdays

Indexes, sectors, biggest movers, rates, top news, SURVYR. model changes and what's ahead. Free, two short emails each weekday.

Editions

Free. Not investment advice. Unsubscribe anytime.

SURVYR

Free to use. No card, no ads, no auto-renew.

Systematic research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

How it worksOur promiseTermsPrivacyData statusSend feedback
Coteau 0.9 · Oct 21, 2026